Wednesday, December 7, 2016

UPDATE 2-EpiPen maker Mylan to restructure and cut its workforce

Dec 7 (Reuters) - Generic drugmaker Mylan NV, which

has been under fire for its price hikes on the life-saving

EpiPen allergy treatment, said on Wednesday that it would

restructure and expected to...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)